Biotech Stocks Rally Hantavirus: Is the Move Overdone?
A limited hantavirus outbreak has sent waves through biotech stocks, mirroring post-pandemic behavior. This article b...
Biotech
Biotech insights await. This page curates 5 articles on Tempus, Moderna, Praxis, ImmunityBio and market moves to help you evaluate stocks and sharpen your portfolio strategy.
119 articles
Axsome Therapeutics Stock Jumped: April Rally and What It Means for Investors
Axsome Therapeutics rode a powerful April rally driven by Auvelity performance and pipeline momentum. This article br...
Overlooked Stocks Soar 2026: Hidden Winners Ahead in 2026
Smart investors look beyond the loud headlines. This guide explains how overlooked stocks soar 2026 by spotting catal...
This Millionaire-Maker Biotech Stock: Worth Buying Now?
What could turn a biotech bet into a life-changing gain? This article breaks down how to spot this millionaire-maker ...
Vericel (VCEL) 2026 Earnings Outlook and Strategy
Vericel faces a pivotal 2026 earnings season. This guide breaks down the drivers behind the numbers, what to watch in...
Crinetics (CRNX) 2026 Earnings Outlook and Analysis
Investors are watching Crinetics' Q1 2026 results for clues on milestones, cash runway, and partnerships. This guide ...
RMTI 2026 Earnings Transcript: What Investors Need
A clear guide to reading RMTI's Q1 2026 earnings call, what the numbers mean, and how to spot the catalysts that can ...
Progyny (PGNY) 2026 Earnings Outlook: What to Expect
As Progyny gears up for 2026, investors want clarity on what drives progyny (pgny) 2026 earnings. This guide breaks d...
Amphastar (AMPH) 2026 Earnings: Q1 Results and Outlook
Amphastar delivered a careful Q1 2026 showing steady revenue momentum and margin discipline. This guide breaks down t...
Xeris (XERS) 2026 Earnings: What Investors Should Know
As Xeris prepares to unpack its Q1 2026 results, investors want clarity on revenue, cash runway, and pipeline milesto...
Arcutis (ARQT) 2026 Earnings Deep Dive and Outlook
Take a practical tour of arcutis (arqt) 2026 earnings, from revenue mix and margins to pipeline progress and risk fac...
Best Obesity Stock Hold for Safe GLP-1 Drug Exposure
Investing in obesity drugs doesn't have to be a gamble. This guide explains why a proven company with real cash flow ...